Pacemaker & Cardiac Device Nursing

A comprehensive clinical reference for GCC nurses covering cardiac pacing fundamentals, temporary and permanent pacemakers, ICD/CRT devices, troubleshooting, and exam preparation aligned to DHA, DOH, and SCFHS standards.

Cardiac Pacing Temporary Pacing PPM Implantation ICD / CRT Troubleshooting GCC Exam Prep
1. Fundamentals 2. Temporary Pacing 3. PPM Implantation 4. ICD & CRT 5. Troubleshooting 6. GCC & Exam Prep
Indications for Cardiac Pacing

Pacing is indicated when symptoms are directly attributable to a low heart rate. Symptoms include:

  • Syncope (sudden loss of consciousness)
  • Pre-syncope (near-fainting, lightheadedness)
  • Dizziness or persistent fatigue
  • Heart failure exacerbation due to low rate
  • Chronotropic incompetence (failure to raise HR with exertion)
Key principle: Asymptomatic bradycardia rarely requires pacing. It is the symptom-rhythm correlation that drives the decision.
Sick Sinus Syndrome (SSS)

Dysfunction of the sinoatrial (SA) node resulting in abnormal impulse generation. Also known as sinus node dysfunction (SND).

ManifestationECG FeatureSignificance
Sinus BradycardiaHR <60 bpm, normal P-wave morphologySymptomatic requires pacing
Sinus ArrestPause >3 sec, no P-waveSyncope risk — pacing indicated
Sinoatrial BlockDropped P-wave, pause = multiple of PP intervalSymptomatic requires pacing
Tachy-Brady SyndromeAlternating SVT/AF then sinus pauseDrug therapy + pacing required
Chronotropic IncompetenceFailure to reach 85% max HR with exerciseRate-responsive pacing (VVIR/DDDR)
AV Block Classification
EMERGENCY: 3rd degree (complete) heart block requires urgent temporary pacing — do not delay for investigations.
DegreeECG CriteriaClinical Action
1st Degree PR interval >200 ms (0.20 sec), all P-waves conduct No treatment required. Monitor. Usually benign.
2nd Degree Mobitz I (Wenckebach) Progressive PR lengthening → dropped QRS; then cycle resets. AV node level block. Usually benign, often vagal/inferior MI. Atropine if symptomatic. Rarely requires pacing.
2nd Degree Mobitz II Fixed PR interval with intermittent non-conducted P-waves. His-Purkinje level block. Unpredictable progression. Permanent pacemaker indicated. Risk of progression to complete block. Temp pacing if acute.
3rd Degree / Complete Block Complete AV dissociation — P-waves and QRS independent. Ventricular escape (wide) or junctional escape (narrow). EMERGENCY pacemaker. Transcutaneous pacing immediately, bridge to transvenous/permanent.
NBG Pacing Code (NASPE/BPEG Generic)

A 5-letter code describing pacemaker programming. The first three positions are most commonly used clinically.

I
Chamber Paced
O, A, V, D
II
Chamber Sensed
O, A, V, D
III
Response to Sensing
O, I, T, D
IV
Rate Modulation
O, R
V
Multisite Pacing
O, A, V, D
A=Atrium, V=Ventricle, D=Dual (both), O=None, I=Inhibited, T=Triggered, R=Rate responsive
ModeDescriptionUse Case
VVIVentricular paced, ventricular sensed, inhibited. Single chamber backup pacing.AF with bradycardia, SSS in AF
VVIRVVI + rate responsive (accelerometer). Increases rate with activity.Chronotropic incompetence, active patients
DDDDual chamber: tracks atrial rate, paces ventricle after AV delay. Physiological.AV block with normal sinus function
DDDRDDD + rate responsive.AV block + chronotropic incompetence
VOOAsynchronous ventricular pacing at fixed rate. Ignores intrinsic activity.Magnet mode, EMI environments, pacemaker-dependent patients
AAIAtrial paced/sensed/inhibited. Requires intact AV conduction.SSS with normal AV conduction
Advanced Concepts

A programmed feature where the escape interval after a sensed beat is longer than the basic pacing interval. Allows intrinsic rhythm to predominate while ensuring backup pacing activates at a slower rate. Preserves natural AV synchrony.

Example

Pacing rate = 60 bpm (1000 ms). Hysteresis rate = 50 bpm (1200 ms). The device waits 1200 ms for intrinsic beat but will pace at 1000 ms once pacing begins.

The "R" suffix in VVIR/DDDR means the pacemaker uses a sensor to increase heart rate in response to physiological demand.

  • Accelerometer: detects body movement/vibration
  • Minute ventilation sensor: detects respiratory rate
  • Mixed sensors: more physiological response
  • Critical for patients with chronotropic incompetence
  • Rate response can be inappropriately triggered by vibration (air travel, road travel)
Indications for Temporary Pacing
  • Acute complete (3rd degree) heart block
  • Symptomatic 2nd degree Mobitz II block
  • Symptomatic bradycardia unresponsive to atropine
  • Post-cardiac surgery bradycardia (epicardial wires)
  • Drug toxicity (digoxin, beta-blocker, CCB)
  • Bridge to permanent pacemaker implantation
  • Overdrive pacing for refractory VT/torsades
Post-MI consideration: Right coronary artery (RCA) infarction causes AV nodal ischaemia → inferior MI with complete block is a common indication for temporary pacing in GCC CCUs.
Transcutaneous Pacing (TCP)
TCP is painful. Sedation/analgesia is mandatory unless patient is unconscious. Use IV morphine 2–4 mg + midazolam 1–2 mg titrated carefully.
  • Apply pads in antero-posterior (AP) position: anterior pad left parasternal V3-V4 position; posterior pad left infrascapular
  • Set mode to DEMAND (synchronised to intrinsic activity) unless cardiac arrest → FIXED
  • Start output at 70–80 mA; increase by 10 mA increments until capture
  • Set rate 60–80 bpm (higher if haemodynamically compromised)
  • Typical capture threshold: 50–100 mA
Electrical capture: Wide QRS after each pacing spike on ECG monitor.

Mechanical capture: Palpate a femoral or carotid pulse — do NOT rely on ECG alone due to muscle artifact. Use pulse oximetry waveform or arterial line if available.
  • Set output 10 mA above threshold once capture confirmed
  • Monitor BP, SaO2 and patient comfort continuously
  • Plan urgent transvenous pacing — TCP is a bridge only
Transvenous Pacing (TVP)
  • Preferred access: right internal jugular vein (IJV) — most direct route to RV
  • Alternatives: subclavian, femoral (higher displacement risk)
  • Lead advanced under fluoroscopy to RV apex
  • Position confirmed: lead tip at apex with slight curve, pacing threshold <1 V, R-wave >5 mV
  • Balloon-tipped (Swan-Ganz style) electrode can be floated without fluoroscopy
ParameterInitial SettingTarget
Rate60–70 bpmHaemodynamically appropriate
Output (mA)5 mA2–3× threshold mA
Sensitivity (mV)2–3 mVAdjust to suppress pacing with intrinsic beats
ModeDemand (VVI)VOO only if no intrinsic activity
Nursing Management of Temporary Pacing
  • Stimulation threshold: Reduce output slowly until capture is lost → threshold = last mA with capture. Set output at 3× threshold (safety margin)
  • Sensing threshold: Reduce sensitivity (increase mV value) until device starts pacing through intrinsic beats → threshold = mV at that point. Set at 50% of threshold
  • Document thresholds every shift and report rising thresholds (suggests lead dislodgement)
  • Secure external lead connections with tape — prevent accidental disconnection
  • Avoid kinking or tension on the pacing wire
  • Sterile dressing changes every 24–48 h
  • Limit patient mobility — educate patient on movement restrictions
  • Label lead clearly: "PACEMAKER WIRE — DO NOT REMOVE"
EMI can inhibit temporary pacing → bradycardia/asystole. Keep patient away from strong electrical fields. Ensure proper patient grounding. Use demand mode unless pacemaker-dependent.
  • Loss of capture: Increase output → check connections → check lead position on CXR → consider reposition
  • Failure to pace (no spikes): Check battery, connections, sensing threshold (over-sensing inhibiting output)
  • Over-sensing: Reduce sensitivity (increase mV number) → reduces detection of extraneous signals
  • Under-sensing: Increase sensitivity (reduce mV number) → better detection of intrinsic beats
Pre-Operative Nursing Preparation

Document that patient/family understands the following risks:

  • Infection: ~1% (pocket infection to endocarditis)
  • Pneumothorax: 1–2% (subclavian approach higher)
  • Lead dislodgement: 2–5% (within first weeks)
  • Pericardial effusion/tamponade: <1%
  • Haematoma: pocket haematoma, especially with anticoagulation
  • Venous thrombosis at access site
  • Antibiotics: Cephalosporin (cefazolin 1–2 g) IV 30 minutes pre-procedure — reduces pocket infection risk by ~50%
  • Anticoagulation: INR target <2.0 for warfarin; DOAC: hold 24–48 h depending on agent and CrCl
  • Skin preparation: Electrical hair clipper — NEVER razor (micro-abrasions increase infection risk)
  • NPO: 6 hours for solids, 2 hours for clear fluids
  • IV access: Contralateral arm to implant side
  • Baseline 12-lead ECG, CXR, FBC, U&E, coagulation screen
  • Consent signed and documented
Implantation Procedure Overview

Procedure Summary (for nursing knowledge)

Performed in catheter lab / EP lab under local anaesthesia ± sedation. Duration 45–90 minutes.

StepDetail
Venous AccessSubclavian, cephalic, or axillary vein — left side preferred. Cephalic vein cut-down has lowest pneumothorax risk.
Lead InsertionVVI: single RV lead. DDD: atrial lead (RA appendage) + ventricular lead (RV apex or RVOT for physiological pacing).
Fluoroscopic GuidanceLead positions confirmed under X-ray. RV lead tip at apex shows left-lateral, inferior, and slightly anterior position.
TestingStimulation threshold, sensing amplitude, and impedance measured for each lead before securing.
Pocket FormationSubcutaneous (subpectoral for thin patients) pocket in infraclavicular region. Device secured, wound closed in layers.
Device ImplantedGenerator connected to leads, programmed to appropriate mode (DDD/VVI etc.).
Post-Operative Nursing Care
  • Continuous cardiac monitoring — confirm pacing mode active, appropriate capture and sensing
  • CXR within 2 hours post-procedure: confirm lead position AND exclude pneumothorax
  • Vital signs every 30 min × 4, then hourly
  • Wound inspection: haematoma, bleeding, dehiscence
  • Observe for signs of cardiac tamponade: hypotension, JVP rise, muffled heart sounds
No arm elevation above shoulder level for 4–6 weeks. Lead dislodgement is the primary risk. Apply sling for first 24–48 hours. Educate patient before discharge.
  • Pressure dressing for first 12–24 hours
  • Keep wound dry for 5–7 days
  • Haematoma: manual compression first; if tense/enlarging → surgical drainage
  • Infection signs: redness, warmth, swelling, discharge, fever — escalate immediately
  • Wound review at 7–10 days
  • Provide device identification card — patient carries at all times
  • Follow-up appointment at 4–6 weeks for device check
  • Arm restriction instructions written and verbal
  • Driving restriction: typically 1 week (non-commercial) — check local regulations
  • Electromagnetic interference (EMI) education
  • MRI labelling: MRI conditional vs MRI non-conditional
MRI & Electromagnetic Interference
  • MRI conditional: Can undergo MRI under specified conditions (1.5T, specific SAR, specific mode). Requires pre-MRI device programming by EP team.
  • MRI non-conditional / legacy devices: MRI contraindicated — risk of lead heating, reed switch activation, programming changes
  • Always check device documentation — patient card shows MRI status
  • All implant dates after ~2013: likely MRI conditional — verify with manufacturer
  • Retail anti-theft devices (EAS systems) — walk through quickly, do not linger
  • Strong industrial magnets, arc welding equipment
  • Airport security: inform staff, request manual screening (wand may be used briefly)
  • Mobile phones: hold to opposite ear, keep 15 cm from device
  • Cautery (surgical diathermy): inform surgical team — use bipolar/lowest effective setting
  • TENS machines, therapeutic ultrasound directly over device site
Household appliances (microwaves, TVs, computers) are generally safe with modern pacemakers.
Implantable Cardioverter Defibrillator (ICD)
CategoryCriteria
Secondary PreventionSurvived VF or haemodynamically unstable VT not due to reversible cause; sustained VT with structural heart disease
Primary PreventionEF ≤35% despite ≥3 months optimal medical therapy (OMT); NYHA II-III; expected survival >1 year with good functional status
ChannelopathiesLong QT, Brugada syndrome, HCM with risk factors, ARVC
ATP (Anti-Tachycardia Pacing): Painless. A burst of rapid pacing stimuli delivered faster than VT rate to terminate it. First-line therapy for detected VT. No shock delivered.
Shock Therapy: Extremely painful (up to 41 Joules). Delivered for VF or VT unresponsive to ATP. Patient typically experiences significant distress — provide psychological support and analgesia post-shock.
ICD Firing: Nursing Management
  • VT/VF detected and terminated — confirm rhythm restored on monitor
  • Patient assessment: consciousness, BP, respiratory status
  • 12-lead ECG immediately post-shock
  • Cardiac biomarkers (troponin, CK) — repeat at 3–6 hours
  • Reassure patient — explain what happened
  • Report to medical team; review trigger (electrolytes, ischaemia, HF exacerbation)
  • Device interrogation by EP team
EMERGENCY — Activate crash team / escalate immediately
  • IV amiodarone 150–300 mg bolus, then 900 mg/24h infusion
  • IV sedation (propofol/midazolam) to reduce sympathetic storm
  • Correct electrolytes: K⁺ >4.5 mmol/L, Mg²⁺ >1 mmol/L
  • Identify and treat precipitant: acute ischaemia, HF, electrolyte disturbance
  • Consider applying magnet over ICD to suspend therapy temporarily while arranging treatment
  • Anaesthesia support for intubation if refractory

Shocks delivered for non-life-threatening rhythms. Causes and management:

CauseMechanismManagement
AF with fast ventricular rateICD detects rapid ventricular rates in AF zone, classifies as VT/VFRate control, reprogramming VT detection threshold
T-wave oversensingTall T-waves counted as R-waves, doubling apparent rateDevice reprogramming (sensing sensitivity adjustment)
Lead fracture / noiseElectrical noise from fractured lead mimics VFLead replacement; apply magnet temporarily
Sinus tachycardiaRapid sinus rate falls in VT detection zoneTreat underlying cause (pain, infection); reprogram
Applying a magnet over an ICD suspends tachycardia detection and therapy delivery. The device continues to pace for bradycardia. Magnet can be used to inhibit inappropriate shocks while definitive management is arranged. Remove magnet to restore ICD function.
Cardiac Resynchronisation Therapy (CRT)
  • Heart failure NYHA II–IV despite OMT
  • EF ≤35%
  • LBBB with QRS ≥130 ms (greatest benefit)
  • Sinus rhythm preferred (evidence weaker in AF)
DeviceFunction
CRT-PCRT + pacemaker. No defibrillation. For NYHA III–IV, elderly.
CRT-DCRT + ICD. Defibrillates and resynchronises. For younger patients, EF ≤35%, primary prevention.
  • LV lead placed via the coronary sinus into a lateral or postero-lateral cardiac vein
  • Sub-costal access approach allows CS cannulation
  • Most technically challenging component of the procedure
  • LV lead most prone to dislodgement
  • AV delay optimisation: Adjusts timing between atrial and ventricular pacing to maximise ventricular filling
  • VV interval optimisation: Adjusts timing between RV and LV stimulation for optimal resynchronisation
  • Performed 4–8 weeks post-implant via echo-guided or device-based optimisation
Subcutaneous ICD (S-ICD)
  • Device placed subcutaneously — no transvenous leads entering the heart or veins
  • Sensing lead tunnelled subcutaneously from xiphoid to left parasternal region
  • Generator implanted in left lateral chest wall
  • Avoids risks of transvenous approach: venous occlusion, infection on leads inside heart
  • Preferred in young patients, those with congenital heart disease, or prior device infections
Limitation: S-ICD CANNOT pace for bradycardia or deliver ATP for VT. It only provides defibrillation shocks. Patients requiring bradycardia pacing or ATP need a transvenous or leadless pacemaker in addition.
  • Requires pre-implant ECG screening (sense vector compatibility)
  • T-wave oversensing more common — requires careful programming
  • No MRI conditional versions currently available (as of 2025)
ECG Interpretation with Pacemakers
  • Pacing spike: narrow, vertical deflection on ECG (may be very small with modern bipolar leads)
  • Atrial spike: precedes P-wave (or no visible P in atrial pacing)
  • Ventricular spike: precedes wide QRS (LBBB morphology for RV apex pacing)
  • DDD mode: may see both A spike → P-wave → V spike → wide QRS
  • RV apex pacing produces LBBB-pattern QRS — dominant S in V1, R in V5/V6
  • RVOT pacing: inferior axis QRS
  • Biventricular (CRT) pacing: narrower QRS, more normal axis

What to look for

  • • Pacing spikes at appropriate rate
  • • Each spike followed by capture (P-wave or QRS)
  • • No spikes when intrinsic beats are present (in demand mode)
  • • AV interval constant in DDD mode
Pacemaker Malfunction: Systematic Approach
ProblemECG FindingCommon CausesNursing Actions
Failure to Pace No pacing spikes when expected (intrinsic rate below programmed rate without spikes) Battery depletion; lead fracture; lead disconnection; over-sensing inhibiting output; programming error Check connections; increase output; check battery indicator; reduce sensitivity; call cardiology urgently if pacemaker-dependent
Failure to Capture Pacing spikes present but NOT followed by P-wave or QRS Lead dislodgement; high pacing threshold (fibrosis); output too low; electrolyte imbalance (hyperK); exit block; lead fracture Increase output; check electrolytes; reposition patient (may help temporarily); arrange urgent device check/CXR; call cardiology
Failure to Sense (Under-sensing) Pacing spikes delivered during intrinsic beats (competitive pacing — R-on-T risk) Sensitivity set too low; lead dislodgement; intrinsic signal amplitude too small; lead fracture; programming Increase sensitivity (reduce mV threshold); call cardiology — R-on-T can precipitate VF
Over-sensing Pauses — pacing inhibited inappropriately; no spikes when intrinsic rate is low Sensitivity set too high; T-wave oversensing; myopotentials (diaphragm, pectoral); EMI; lead fracture noise Decrease sensitivity (increase mV threshold); remove EMI source; call cardiology; apply magnet to convert to asynchronous mode if pacemaker-dependent
Special Syndromes

Occurs in VVI pacing when AV synchrony is lost. Retrograde VA conduction causes atria to contract against closed AV valves.

  • Symptoms: palpitations, presyncope, fatigue, neck pulsations (cannon A-waves), dyspnoea
  • Drop in BP ≥20 mmHg with VVI pacing compared to native rhythm
  • Management: reprogram to DDD (dual chamber) to restore AV synchrony

Occurs in DDD pacemakers. Retrograde P-wave (from conducted ventricular beat) is sensed by atrial channel → triggers ventricular pacing → loop continues at upper rate limit.

  • ECG: tachycardia at upper rate limit with consistent AV pacing pattern
  • Management: apply magnet (converts to asynchronous — breaks re-entry loop)
  • Long-term: programme PVARP extension; increase post-ventricular atrial refractory period
Lead & Device Complications
ComplicationTimingSignsManagement
Lead DislodgementEarly (<4 weeks)Failure to pace/capture; new RBBB morphology for RV lead; CXR shows lead tip not at apexUrgent repositioning in EP lab; bed rest; limit arm movement
Lead FractureLate (>months)Intermittent sensing/pacing failure; noise on ECG; high impedance on interrogationLead replacement or extraction; avoid strenuous activity pending fix
Insulation BreachVariableLow impedance; inappropriate shocks (ICD); oversensingLead replacement
Pocket InfectionDays to monthsRedness, warmth, swelling, fluctuance, discharge, fever, elevated CRP/WBCIV antibiotics; lead extraction + device removal; reimplant contralateral side after adequate treatment
Device EndocarditisWeeks to monthsFever, bacteraemia, vegetations on echo, positive blood culturesIV antibiotics 4–6 weeks; complete lead extraction; multidisciplinary team decision on reimplantation
Pocket HaematomaEarly (24–72 h)Swelling, bruising, tenderness over pocketManual compression; wound support; drain if tense or expanding; review anticoagulation
PneumothoraxImmediateDyspnoea, pleuritic chest pain, reduced breath sounds, CXR confirmationSmall: observe; large/symptomatic: chest drain
GCC Regional Context
  • GCC nations have high burden of cardiovascular risk factors: diabetes (prevalence 15–20%), hypertension, obesity, sedentary lifestyle — driving demand for pacing services
  • Ischaemic heart disease is the leading cause of AV block requiring pacing in GCC
  • Rapid population growth and expanding tertiary care infrastructure increasing implantation rates year-on-year
  • Large expatriate population with varied cultural background requires nuanced communication for device acceptance and follow-up adherence
  • Advanced MRI scanners widely available in tertiary hospitals across UAE, KSA, Qatar
  • High frequency of MRI requests in pacemaker patients — critical that nurses document device MRI status
  • Always check patient device card and confirm with EP team before any MRI request
  • MRI-conditional protocol involves: EP team reprogramming, MRI team supervision, immediate post-MRI device check
  • King Faisal Specialist Hospital (KFSH), Riyadh & Jeddah, KSA — pioneer cardiac EP services in GCC
  • Cleveland Clinic Abu Dhabi, UAE — comprehensive EP programme including lead extraction
  • Hamad Medical Corporation (HMC), Qatar — national cardiac centre, growing EP volume
  • King Abdullah Medical City (KAMC), Makkah, KSA
  • Mediclinic / SEHA network (UAE) — distributed pacemaker services
  • King Hamad University Hospital, Bahrain
  • SCFHS — Saudi Commission for Health Specialties (KSA nursing licence & exam)
  • DHA — Dubai Health Authority (Dubai nursing licence)
  • DOH — Department of Health Abu Dhabi (Abu Dhabi nursing licence)
  • QCHP — Qatar Council for Healthcare Practitioners
  • NHRA — National Health Regulatory Authority (Bahrain)
GCC Exam Practice — 10 MCQs

Click an answer to check. Relevant to DHA, DOH, SCFHS cardiac nursing examinations.

Interactive Pacemaker ECG Analyser

Pacemaker Function Analyser

Answer the questions below based on the ECG you are reviewing to determine pacemaker status and required actions.

Possible Causes

    Immediate Nursing Actions

      When to Call Cardiology / EP Team